Albers RW, Brady RO (1959) The distribution of glutamate decarboxylase in the nervous system of the rhesus monkey. J Biol Chem 234:926–928

PubMed  CAS  Google Scholar 

Arnt J, Scheel-Krüger J (1980) Intranigral GABA antagonists produce dopamine-independent biting in rats. Eur J Pharmacol 62:51–61

Article  PubMed  CAS  Google Scholar 

Baimbridge KG, Parkes CO, Miller JJ (1982) Calcium-binding protein distribution in the rat brain. Brain Res 239:519–525

Article  PubMed  CAS  Google Scholar 

Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254

Article  PubMed  CAS  Google Scholar 

Casey DE (1984) Tardive dyskinesia — animal models. Psychopharmacol Bull 20:376–379

PubMed  CAS  Google Scholar 

Casey DE (1985) Tardive dyskinesia: reversible and irreversible. In: Casey DE, Chase TN, Christensen TR, Gerlach J (eds) Dyskinesia research and treatment. Psychopharmacology [Suppl 2]. Springer, Berlin Heidelberg New York, pp 88–97

Google Scholar 

Casey DE, Gerlach J, Christensson E (1980) Dopamine, acetylcholine and GABA effects in acute dystonia in primates. Psychopharmacology 70:83–87

Article  PubMed  CAS  Google Scholar 

Coward DM (1982) Nigral actions of GABA agonists are enhanced by chronic fluphenazine and differentiated by concomitant flurazepam. Psychopharmacology 76:294–298

Article  PubMed  CAS  Google Scholar 

Fann WE, Lake CR, Gorber CJ, McKenzie GM (1974) Cholinergic suppression of tardive dyskinesia. Psychopharmacology 37:101–107

Article  CAS  Google Scholar 

Fonnum F (1975) A rapid radiochemical method for the determination of choline acetyl transferase. J Neurochem 24:407–409

PubMed  CAS  Google Scholar 

Gerfen CR, Baimbridge KG, Miller JJ (1985) The neostriatal mosaic: compartmental distribution of calcium-binding protein and parvalbumin in the basal ganglia of the rat and monkey. Proc Natl Acad Sci USA 82:8780–8784

Article  PubMed  CAS  Google Scholar 

Glassman RB, Glassman HN (1980) Oral dyskinesia in brain-damaged rats withdrawn from a neuroleptic: implication for models of tardive dyskinesia. Psychopharmacology 69:19–25

Article  PubMed  CAS  Google Scholar 

Gunne L-M, Haggstrom J-E (1983) Reduction of nigral glutamic acid decarboxylase in rats with neuroleptic-induced oral dyskinesia. Psychopharmacology 81:191–194

Article  PubMed  CAS  Google Scholar 

Gunne L-M, Growdon J, Glaeser B (1982) Oral dyskinesias in rats following brain lesions and neuroleptic drug administration. Psychopharmacology 77:134–139

Article  PubMed  CAS  Google Scholar 

Gunne L-M, Haggstrom J-E, Sjoquist B (1984) Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA-synthesis. Nature 309:347–349

Article  PubMed  CAS  Google Scholar 

Haggstrom J-E, Anderson U, Gunne L-M (1981) Bromocriptine in tardive dyskinesia. Pharmacopsychiatria 15:161–163

Article  Google Scholar 

Horton RW, Jenner P, Marsden CD, Prestwich SA, Rupniak NMJ (1985) Alterations in cerebral GABA parameters following treatment of rats for up to 1 year with haloperidol, sulpiride or clozapine. Br J Pharmacol 86:472P

Hunter WM, Greenwood FC (1962) Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature 194:495–496

Article  PubMed  CAS  Google Scholar 

Lloyd KG, Hornykiewicz O (1977) Effect of chronic neuroleptic orl-dopa administration on GABA levels in the rat substantia nigra. Life Sci 21:1489–1496

Article  PubMed  CAS  Google Scholar 

Lloyd KG, Worms P, Depoortere H, Bartholini G (1979) Pharmacological profile of SL 76002, a new GABA-mimetic drug. In: Korsgaard-Larsen P, Scheel-Krüger J, Kofod H (eds) GABA-neurotransmitters. Munksgaard, Copenhagen, pp 308–312

Google Scholar 

Lowry OH, Rosebrough NJ, Farr AL, Randall AJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:259–265

Google Scholar 

McGeer PL, McGeer EG, Wada JA, Jung E (1971) Effects of globus pallidus lesions and parkinson's disease on brain glutamic acid decarboxylase. Brain Res 32:425–431

Article  PubMed  CAS  Google Scholar 

Mao CC, Cheney DL, Marco E, Revuelta A, Costa E (1977) Turnover times of gamma-butyric acid and acetylcholine in nucleus caudatus, nucleus accumbens, globus pallidus and substantia nigra: effects of repeated administration of haloperidol. Brain Res 132:375–379

Article  PubMed  CAS  Google Scholar 

Marco E, Mao CC, Revuelta A, Peralta E, Costa E (1978) Turnover rates of τ-aminobutyric acid in substantia nigra, n. caudatus, globus pallidus and n. accumbens of rats injected with cataleptogenic and noncataleptogenic antipsychotics. Neuropharmacology 17:589–596

Article  PubMed  CAS  Google Scholar 

Nair NPV, Yassa R, Ruiz-Nararro J, Schwartz G (1980) Baclofen in the treatment of tardive dyskinesia. Am J Psychiatry 135:1556–1663

Google Scholar 

Rastogi SK, Rastogi RB, Singhal RL, Lapierre YD (1983) Behavioural and biochemical alterations following haloperidol treatment and withdrawal: the animal model of tardive dyskinesia reexamined. Prog Neuro-Psychopharmacol Biol Psychiatry 7:153–164

Article  CAS  Google Scholar 

Rupniak NMJ, Jenner P, Marsden CD (1983) Cholinergic manipulation of perioral behavior induced by chronic neuroleptic administration to rats. Psychopharmacology 79:226–230

Article  PubMed  CAS  Google Scholar 

Rupniak NMJ, Jenner P, Marsden CD (1985) Pharmacological characterization of spontaneous or drug associated purposeless chewing movements in rats. Psychopharmacology 85:71–79

Article  PubMed  CAS  Google Scholar 

Simpson GM, Lee JH, Shrivastava RK, Branchey MH (1978) Baclofen in the treatment of tardive dyskinesia and schizophrenia. Psychopharmacol Bull 14:16–18

PubMed  CAS  Google Scholar 

Stahl SM, Thornton JE, Simpson ML, Berger PA, Napoliello J (1985) Gamma-vinyl-GABA treatment of tardive dyskinesia and other movement disorders. Biol Psychiatry 20:888–893

Article  PubMed  CAS  Google Scholar 

Tamminga CA, Crayton JW, Chase TN (1979) Improvement in tardive dyskinesia after muscimol therapy. Am J Psychiatry 36:746–747

Google Scholar 

Tamminga CA, Thaker GK, Ferraro TN, Hare TA (1983) GABA agonist treatment improves tardive dyskinesia. Lancet II:97–98

Article  Google Scholar 

Waddington JL, Molloy AG (1987) The status of late-onset vacuous chewing/perioral movements during long-term neuroleptic treatment in rodents: tardive dyskinesia or dystonia? Psychopharmacology 91:136–137

Article  PubMed  CAS  Google Scholar 

Waddington JL, Cross AJ, Gamble SJ, Bourne RC (1983) Spontaneous orofacial dyskinesia and dopaminergic function in rats after 6 months of neuroleptic treatment. Science 220:530–532

PubMed  CAS  Google Scholar 

Wasserman RH (1985) Nomenclature of the Vitamin D induced calcium-binding proteins. In: Norman AW (ed) Vitamin D. de Gruyter, Berlin, pp 321–323

Google Scholar